Navigation Links
Last chance for media to register for ECCO 14 -- the European Cancer Conference

If you have any questions (media only), contact: Emma Mason, ECCO 14 media consultant, tel: +44 (0)1376 563090, mobile: +44 (0)7711 296 986, email: or Mary Rice, FECS media consultant, tel: +32 (0)2 770 0407, mobile: +44 (0)780 304 8897, email:

Any enquiries about registration and hotel accommodation for non-media should be directed to the FECS office (www.

Only a few days left for media to register for Europes premier cancer conference! Visit for details of how to register to attend.

Sunday 23 September to Thursday 27 September 2007 Centro de Conveniones Internacional de Barcelona (CCIB) and the Forum Building Auditorium, Barcelona, Spain

In more than 1,300 presentations from scientists working in 75 countries, the conference will discuss the latest advances in stem cell research, proteomics, biomarkers, pharmacogenomics, imaging, treatment and coping with life after cancer, as well as the latest evidence on epidemiological trends, complementary therapies, quality of life issues and the influence of lifestyle choices on the development and outcome of cancer. The programme includes more new results from phase III clinical trials than ever before.

There will be media news briefings at the following times:

  • Monday 24 September (11.00 hrs) in English

  • Monday 24 September (14.30 hrs) in Spanish (embargoed to Tuesday 25 September)

  • Tuesday 25 September (11.00 hrs) in English

  • Wednesday 26 September (11.00 hrs) in English

  • Thursday 27 September (10.30 hrs) in English

Here is a sample of the new results to be announced at the conference (embargoed to time of presentation at ECCO 14):

  • Discovery of gene with widespread involvement in stimulating tumour growth holds out promise for treating many common cancers
  • Tumour cells circulating in blood can predict which patients are likely to have a recurrence of cancer after chemotherapy treatment
  • Figures on cancer control in Europe show it works; now it is time to extend it to poorer countries
  • Threat to MRI scans from European Directive how it will affect cancer diagnosis and treatment
  • Identification of molecular fingerprint for resistance to commonly used chemotherapy drug can predict response to treatment in breast cancer
  • Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
  • Improved treatment for difficult childhood brainstem gliomas
  • First molecular profiling of colon cancer patients accurately predicts survival
  • Quality of life after endometrial cancer treatment can be significantly improved by the use of internal rather than external radiotherapy
  • Survey reveals ignorance and confusion about cancer among the elderly
  • Researchers discover a specific genetic mutation can double or treble a womans risk of ovarian cancer
  • Researchers discover PET is more useful than mammography or ultrasound in detecting a tumours response to chemotherapy and the patients likelihood of survival
  • Can acupuncture reduce radiotherapy-induced nausea" New findings.
  • Study of 70,000 women reveals whether wine, beer or spirits are most likely to trigger the onset of breast cancer, or whether they are all as bad as each other
  • post traumatic stress symptoms in adolescent children of cancer patients do their parents realise"
  • study fuels debate over whether body size and exercise influence ovarian cancer risk
  • Chemotherapy drug delays progression of operable pancreatic cancer
  • Married oesophageal cancer patients fare worse than their single counterparts in some aspects of quality of life
  • Experimental drug shows promise in advanced kidney cancer patients whose options run out after their tumour fails to respond to the cutting edge therapy
  • New findings on pregnancy and cancer survival
  • Couples more likely to divorce if one partner is diagnosed with certain types of cancer
  • New type of drug shows promise in tackling melanoma in innovative way. . . . and much more.

Press Office opening times:
Sunday 23 September: 09.00 19.00
Monday 24 Wednesday 26 September: 08.00 19.00
Thursday 25 September: 08.00 14.00

Registration and accommodation (media only)

ECCO 14 is open to bona fide representatives of print and electronic media and healthcare media. Registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication. Details of how to register and how to obtain accommodation can be found on the FECS website at:

Journalists must register in person. Applications for media registration made via pharmaceutical, marketing or public relations companies will not be considered.

Contact: Emma Mason
Federation of European Cancer Societies

Related biology news :

1. Minor mutations in avian flu virus increase chances of human infection
2. Study finds that a womans chances of having twins can be modified by diet
3. New dwarf buffalo discovered by chance in the Philippines
4. Heavy smoking cuts womens chance of pregnancy -- even with donated oocytes
5. Like salty food? Chances are you had low blood sodium when you were born
6. To sleep, perchance to dream: New insight into melatonin production
7. Gene sequencing explains bioremediation bug
8. FDA Warns Consumers Not to Use Home-Use Diagnostic Kits Marketed by Globus Media
9. Activation of thermoreceptors mediates raw garlics burning pungency
10. A hope for oil spill bioremediation
11. Leading scientists rank endangered dolphins, porpoises most in need of immediate action
Post Your Comments:
(Date:11/20/2015)... , November 20, 2015 NXTD ... focused on the growing mobile commerce market and creator ... Gino Pereira , was recently interviewed on The ... air on this weekend on Bloomberg Europe , ... . --> NXTD ) ("NXT-ID" or the ...
(Date:11/19/2015)... Calif. , Nov. 19, 2015  Based on ... Frost & Sullivan recognizes BIO-key with the 2015 Global ... Each year, Frost & Sullivan presents this award to ... line catering to the needs of the market it ... product line meets and expands on customer base demands, ...
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 25, 2015 2 nouvelles études ... les différences entre les souches bactériennes retrouvées dans ... des êtres humains . Ces recherches  ouvrent une ... la prise en charge efficace de l,un des ... les chats .    --> 2 nouvelles ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
Breaking Biology Technology: